Skip to main content

Emergent BioSolutions Inc 10-Q for FY2024 Q2

Emergent BioSolutions Inc. (EBS)

10-Q 2024-08-07 For: 2024-06-30
View Original
Added on April 01, 2026

About this 10-Q

Emergent BioSolutions Inc filed this 10-Q on August 7, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$254.7M
down 24.6% from $337.9M a year earlier
Net loss
$283.1M
compared with a net loss of $261.4M a year earlier
Diluted EPS
-$5.38
compared with -$5.16 a year earlier